Humana Inc (HUM · NYSE)

HUM · MARKET VIEW

Market view · as of Jun 22, 2026

Revenue (TTM)
$137.20B
+23.5% YoY
Gross margin
14.0%
EPS (latest q)
$10.31
vs $10.20 est · beat
52-wk position
91.0%
-5.2% vs 52w high · +18.6% 1mo

Price (last ~year)

Humana Inc. (HUM) reported a 23.5% year-over-year revenue increase, reaching $137.20 billion in trailing twelve-month revenue, with the quarter ending March 31, 2026, delivering $39.65 billion in revenue and $1.19 billion in net income. The company has outperformed earnings estimates in each of the last four quarters and recently received a positive impact from a CMS re-evaluation of Medicare Advantage star ratings. Humana currently holds a market capitalization of $43.30 billion, a P/E ratio of 38.45, and is trading at $360.65.

Valuation

Market cap
$43.30B
P/E
38.45
PEG
2.043
P/B
2.33
P/S
0.316
Beta
0.771
Analyst target
$301.62

Quality & returns

Gross margin
14.0%
Operating margin
4.7%
Profit margin
0.8%
ROE
6.3%
ROA
3.6%

Price movement

Last
$360.65
1-month
+18.6%
3-month
+110.5%
RSI (14)
75
vs SMA200
+45.7%
52-wk position
91.0% -5.2% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$39.65B$1.58B$1.19B$1.97B
2025-12-31$32.52B$-1.02B$-796.0M$-685.0M
2025-09-30$32.65B$108.0M$195.0M$480.0M
2025-06-30$32.39B$722.0M$545.0M$1.09B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots